Gossamer Bio, Inc. GOSS
- seralutinib — Pulmonary Arterial Hypertension NDA Submitted
- seralutinib — Pulmonary Hypertension associated with Interstitial Lung Disease Phase 3
c-KIT (1 companies · 2 programs)
Companies with an active program directed at c-KIT.